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We examined the HIV care cascade in a community-based cohort study in Kisesa, Magu, 
Tanzania. We analyzed the proportion achieving each stage of the cascade - 
Seroconversion, Awareness of HIV status, Enrollment in Care and Antiretroviral therapy 
(ART) initiation- and estimated the median and interquartile range for the time for 
progression to the next stage. Modified Poisson regression was used to estimate 
prevalence risk ratios for enrollment in care and initiation of ART.  
From 2006 to 2017, 175 HIV-seroconverters were identified. 140(80%) knew their HIV 
status, of whom 97(69.3%) were enrolled in HIV care, and 87(49.7%) had initiated ART. 
Time from seroconversion to awareness of HIV status was 731.3[475.5-1345.8] days. 
Time from awareness to enrollment was 7[0-64] days, and from enrollment to ART 
initiation was 19[3-248] days. There were no demographic differences in enrollment in 
care or ART initiation.  Efforts have been focusing on shortening time from 
seroconversion to diagnosis, mostly by increasing the number of testing clinics available. 
We recommend increased systematic testing to reduce time from seroconversion to 
awareness of status, and by doing so speed up enrollment into care. Interventions that 
increase enrollment are likely to have the most impact in achieving UNAIDS targets. 
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Introduction 
The target for antiretroviral therapy (ART) programs worldwide has been defined 
by the Joint United Nations Programme (UNAIDS) using the slogan 90-90-90 targets 
(UNAIDS, 2017). This aims to achieve 90% of people living with HIV (PLHIV) 
diagnosed (knowing their status), 90% of those diagnosed initiated on ART, and 90% of 
individuals on ART being virologically suppressed. Reaching the UNAIDS targets 
requires early diagnosis, effective linkage to treatment, and maintaining patients in care 
(Kunutsor et al., 2011; Ulett et al., 2009). Not only is it important to be aware of the 
presence and nature of obstacles to care, but identification of key factors associated with 
linkage to care are also needed to improve benefits of ART through the continuum of 
care (Nakagawa et al., 2012). 
We used data from a community-based cohort in Tanzania to assess the spectrum 
of engagement in care of PLHIV in Northwest Tanzania and estimate the achievement of 




The data for this paper is derived from a community-based cohort study in Kisesa, 
Tanzania, covering an area of about 115 km2 with 35000 inhabitants residing in the study 
area (Boerma et al., 1999; Mwaluko et al., 2003, Kishamawe et al., 2015). Approximately 
every 3 years all residents aged 15 years or more are invited to a sero-survey to determine 
the health needs in the population, with the first in 1994, and the 8th sero-survey finished 
in February 2016. All sero-survey participants were offered Voluntary Counseling and 
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Testing (VCT), and if found to be HIV-infected were referred to the main clinic in Kisesa 
for treatment. Dried blood spot samples (DBS) from all consenting participants, whether 
or not they had VCT, were tested for HIV-1 at the National Institute for Medical 
Research (NIMR) reference laboratory in Mwanza. We identified seroconverters from 
HIV testing of DBS between September 2006 (sero-survey 5) and February 2016 (sero-
survey 8). Seroconverters were defined as those with at least one HIV negative test, and a 
subsequent HIV positive test, with the date of seroconversion defined as the mid-point 
between dates of the last negative test and the first positive test.  
 
Three stages of the HIV care cascade were included in our framework: 
 
1) Awareness of HIV status: defined as the awareness of positive HIV status either 
through VCT at the sero-survey, or through self-reported HIV Counseling and Testing 
(HCT) attendance or other proof of HCT (available in public health facilities unrelated to 
the sero-surveys). The date of awareness of HIV status was defined as the date the person 
first knew of his or her own HIV status.  
 
2) Enrollment in HIV care: defined as completing and/or self-reporting at least 1 
visit to a Care and Treatment Clinic (CTC). Those diagnosed with HIV through a positive 
HIV test at any of the HCT clinics, or through VCT in the sero-surveys, are referred to a 
CTC. The date of CTC enrolment was defined as the date of the first reported attendance 
at CTC.  
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3) ART initiation: defined as having a clinically confirmed ART initiation report 
and/or self-reported use of ART. The date of ART initiation was defined as the first 
reported date that ART was given to participants. 
 
Follow-up 
The follow-up period spanned from date of seroconversion to March 15th 2017, 
the date at which everyone who had not progressed to the next stage was censored. We 
searched for each seroconverter manually and via a record linkage computer algorithm 
using name, sex, date of birth, and place of residence in all the health clinics providing 
HIV care within a 10 km radius around the sero-survey catchment area. We additionally 
visited the two oldest and largest HIV clinics in the region (in Mwanza City, 20 km from 
the DSS) to search for seroconverters. 
 
Statistical analysis 
The proportion of HIV-positive persons achieving each stage in the cascade was 
calculated.  Statistical inference for differences between levels of explanatory variables 
was based on a χ2 test for categorical variables. We also used modified Poisson 
regression to estimate prevalence risk ratios (PRRs) and 95% confidence intervals 
(95%CIs) for enrollment in care and initiation of ART. All plausible variables were 
individually included into the model and model goodness-of-fit assessed. Data were 
entered into Microsoft Excel and all analyses were performed in STATA 14.1 (College 




Ethical approval for retrospective analysis of these data was obtained from 
Bugando Medical Centre in Mwanza (BREC/001/04/2011), the National Institute for 
Medical Research in Dar es Salaam (NIMR/HQ/R.8a/Vol.IX/1489), and Weill Cornell 
Medicine in New York (1108011883). Study participants provided consent at the time of 
enrollment into the cohort study in accordance with the approved procedures of the 
TAZAMA project (Boerma et al., 1999; Mwaluko et al., 2003). 
 
Results 
From September 2006 to February 2017, a total of 207 HIV-seroconverters were 
identified in the cohort. Among those, 175 HIV-seroconverters were available for follow-
up. A total of 20 health facilities (HCTs and CTCs) contributed to the analysis.  
The demographics of the HIV-seroconverters are presented by stage of the 
cascade in Table I. There was no difference in the proportions of HIV-seroconverters by 
area of residence.  
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Table I. Proportion of the 175 HIV-seroconverters engaged in each of the HIV care 





Aware of HIV status Enrolled in care Initiated ART 
  n (%)  p-
valuea 




Total 175 140 (80.0%) - 97 (55.4%) - 87(49.7%) - 
Sex 
Female 118 (67.4%) 93 (78.8%) 0.57 69 (58.5%) 0.24 63 (53.4%) 0.16 
Male 57 (32.6%) 47 (82.5%) 28 (49.1%) 24 (42.1%) 
Occupation 
Farmer 142 (81.1%) 111 (78.2%) 0.42 74 (52.1%) 0.17 69/142 
(48.6%) 
0.77 
Businessman 12 (6.9%) 11 (91.7%) 9 (75.0%) 6/12 (50.0%) 
Mix of farming 
and business 
21 (12.0%) 18 (85.7%) 14 (66.7%) 12/21 (57.1%) 
 










initiated   
36 (27-46) 36.5 (28-46) 0.46 35(27-43) 0.15 36.5 (27.5-48) 0.42 
Not aware/ 
enrolled/initiated 
34 (26-43) 37(28-52) 36 (27-45) 
Years of education 
Aware/enrolled/ 
   initiated   
7(2-7) 7(2-7) 0.75 7(0-7) 0.16 7 (3.5-7) 0.062 
Not aware/ 
  enrolled/initiated 
7(0-7) 7(3-7) 7 (0-7) 
a Use of Chi-square test for categorical variables and rank-sum test for continuous 
variables. 
 
As of March 2017, end of follow-up, 140/175 (80.0%) knew their HIV status, 
97/175 (55.4%) were enrolled in HIV care, and 87/140 (62.1%) had initiated ART.  The 




Figure 1. Cascade of care in the study population, Tanzania. The first two 90-90-90 
targets are in bold. 
Figure 1 depicts the cascade of care in our study population. 80% of HIV-infected 
people knew their HIV status and 62% of these were on ART. 
 
 
The majority of the seroconverters learned about their positive status for the first 
time at the sero-survey (67/140, 47.8%), or at a HCT clinic (47/140, 33.6%). 20/140 
(14.3%) of the seroconverters discovered their status via provider-initiated testing and 
6/140 (4.3%) at Ante-Natal Care (ANC).  
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The median time from seroconversion to being aware of one’s HIV status was 
731.3[475.5-1345.8] days while time from awareness of HIV status to enrollment was 
7[0-64] days. The overall median time from enrollment to ART initiation was 19[3-248] 
days. The key time variables are presented in Table II.  
 
Table II. Key time variables (in days) for the 175 seroconverters 
IQR=Interquartile range 
Variable Median IQR Minimum Maximum N 
Time from seroconversion to awareness 731.3 475.5 - 1345.8  135.5 2889 140 
Time from seroconversion to enrollment 965.5 511.5 - 1652.5 135.5 2889 93a 
Time from seroconversion to ART 
initiation 
1247.5 803.5 - 1867.5 206.5 3324.5 83a 
Time from awareness to enrollment 7.0 0 - 64 0 2170 93a 
Time from awareness to ART initiation 146.0 19 - 535 0 2989 83a 
Time from enrollment to ART initiation 19.0 3 - 248 0 2988 83a 
Time being followed-up at the clinic (up 
to March 15th 2017) 
803.0 378 - 1646 64 3009 93a 
 a 4 people self-reported attending a clinic and initiation ART but did not provide us with 
exact dates. 
 
Time to ART initiation decreased sharply with the successive implementation of 
new guidelines. Time from awareness of HIV status to enrollment transiently increased 
with the creation of new clinics where old seroconverters who had not previously been 
enrolled in care could now enroll in care more easily. Throughout the study period, the 
time from awareness of HIV status to enrollment was longer for those receiving their 
results at sero-surveys than for those receiving their results at a clinic (p<0.001). These 





Figure 2: Variations in reaching each stage of the cascade by year of enrollment  
Figure 2 shows the variation in key time variables over the years, following major 
HIV/AIDS testing and care interventions.  Time to ART initiation decreased dramatically 
with the successive implementation of new guidelines while time from diagnosis to 
enrollment transiently increased with the creation of new clinics. The first sero-survey 
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There was no difference by sex in enrollment in care (adjPRR=0.85, 95%CI 0.61-
1.17), and no other significant differences. There was also no difference by sex in ART 
initiation (adjPRR=0.75, 95%CI 0.51-1.08), and no other significant differences.  
There was no difference in occupation, age or years of education in any of the stages of 
the cascade of care. 
 
Discussion 
This is the first report, to our knowledge, on Tanzania’s achievements regarding 
the 90-90-90 targets. This longitudinal study in Tanzania occurred at a unique time 
during which new HIV clinics were opening and ART eligibility was increasing. Our 
Tanzanian study population demonstrates some moderate successes, with 80% of HIV-
infected people knowing their HIV status and 62% of these on ART. Routine viral load 
monitoring was not yet fully implemented at the time of our study and future studies will 
evaluate the 3rd target of the UNAIDS 90-90-90 goal. 
 
The success in our rural study population is that the percentage of HIV-positive 
individuals knowing their status is high. This effect was largely driven by the recent 
strategy change of the final sero-survey in 2016, which provided opt-out HIV testing for 
all participants rather than requiring the person providing blood to take initiative to obtain 
their results. This highlights the need for more regular access to opt-out testing and a 
greater encouragement for uptake of HIV testing (Church et al., 2017). This would also 
help reduce time from seroconversion to awareness of HIV status, which is still the main 
reason for substantial delays in enrollment into care in our cohort. Due to the logistical 
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challenges and the expense of large-scale sero-surveys, provider-initiated testing might 
be more able to fit those criteria (Sanga et al., 2017). 
 
Gender was not a predictive factor for initiating ART in our study population, 
which was unexpected and inconsistent with other studies (Hatcher et al., 2012; Lahuerta 
et al., 2014), as women have been accessing ART when pregnant, regardless of CD4 
counts for the past 7 years. It could be explained by the fact that very few women in our 
study population received their HIV results through ANC. No other demographic factor 
predicted enrollment into care or initiation of ART, which strongly suggests that failure 
in linkage to care is inherent to the system, and not due to patient factors (Church et al., 
2017 , Mshana et al., 2006).  Integration of HIV care services remains a substantial 
problem in this setting, despite the availability of free services in close geographic 
proximity. Effective referral must be strengthened if linkage to HIV treatment is to be 
improved. More specifically, individuals who were diagnosed at a HCT clinic were more 
rapidly linked to CTC than those diagnosed at sero-surveys in our study population, as 
was shown in other regions of Tanzania as well (Sanga et al., 2017). This highlights the 
need for better integration of the sero-surveys into the HIV healthcare system and more 
efficient referral of the patients to the CTC clinics. 
 
The target of 90% of the population diagnosed with HIV being on ART is still far 
from being achieved in our study population. This is likely due to both a low percentage 
of diagnosed individuals going into care and treatment and to changes in guidelines based 
on CD4 counts over the duration of our observational period. 
	 13	
The low percentage of diagnosed individuals going into care and treatment can be 
explained partially by the fact that not many easily accessible CTCs were opened until 
2014. In fact, before 2014 there were only 5 CTCs in the region, and those were far away 
for the majority of the rural population, with over an hour of walk needed to reach the 
facilities. Thus the increasing time from seroconversion to enrollment in care over the 
years is indeed the result of more old seroconverters enrolling in CTCs as they open.  
 
CD4-count based guidelines would be the second reason for low ART initiation. 
Until 2010, the criteria for ART initiation were a CD4 count ≤200 cells/mm3 or a WHO 
clinical stage of 4 for all adults. The criteria changed to ≤350 cells/mm3 from 2010-2012, 
≤500 from 2013-2015, and all HIV-infected in 2016. (The United Republic of Tanzania. 
Ministry of Health, Community Development, Gender, Elderly and Children, 2017; The 
United Republic of Tanzania. Ministry of Health, 2005; The United Republic of 
Tanzania. Ministry of Health and Social Welfare., 2012, 2015).The WHO guideline of 
initiating ART for all HIV-infected people was issued in 2015 and has been rolled out 
gradually since then in Tanzania. Not only do the new patients now need to initiate ART 
immediately, but the older patients who had not gotten on ART based on previous 
guidelines still need to start ART. It will take a few years for each clinic to overcome the 
lag but this approach for treatment will ultimately lead to an ongoing and consistent 
improvement in the number of individuals on antiretroviral therapy.  
Importantly, more CTCs continue to open in the region and the country and 
home-based testing is also currently being investigated in Tanzania (Lwezaula, 2012). 
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Both of these will likely serve as powerful resources to strengthen linkage of HIV-
infected individuals to testing and care. 
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